Caturano A, Erul E, Nilo R, Nilo D, Russo V, Rinaldi L
Mol Cell Biochem. 2025; .
PMID: 40089612
DOI: 10.1007/s11010-025-05245-8.
Kuhl G, Tangney M
Cancers (Basel). 2025; 17(5).
PMID: 40075571
PMC: 11899205.
DOI: 10.3390/cancers17050723.
Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y
Signal Transduct Target Ther. 2025; 10(1):93.
PMID: 40055311
PMC: 11889221.
DOI: 10.1038/s41392-025-02124-y.
Hua Q, Li Z, Weng Y, Wu Y, Zheng L
Front Med. 2025; .
PMID: 40048137
DOI: 10.1007/s11684-025-1124-8.
Kuang J, Li J, Zhou S, Li Y, Lin J, Huang W
Discov Oncol. 2025; 16(1):241.
PMID: 40009285
PMC: 11865409.
DOI: 10.1007/s12672-025-01976-8.
Insights into CSF-1/CSF-1R signaling: the role of macrophage in radiotherapy.
Shang Q, Zhang P, Lei X, Du L, Qu B
Front Immunol. 2025; 16:1530890.
PMID: 40007537
PMC: 11851012.
DOI: 10.3389/fimmu.2025.1530890.
Extracellular Vesicle-Based Strategies for Tumor Immunotherapy.
Jiramonai L, Liang X, Zhu M
Pharmaceutics. 2025; 17(2).
PMID: 40006624
PMC: 11859549.
DOI: 10.3390/pharmaceutics17020257.
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy.
Toghraie F, Bayat M, Hosseini M, Ramezani A
Cell Oncol (Dordr). 2025; .
PMID: 39998754
DOI: 10.1007/s13402-025-01051-y.
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction.
Verona F, Di Bella S, Schirano R, Manfredi C, Angeloro F, Bozzari G
Front Immunol. 2025; 16:1529847.
PMID: 39981232
PMC: 11839637.
DOI: 10.3389/fimmu.2025.1529847.
Immunomodulatory role of exosome-derived content in pediatric medulloblastoma: a molecular subgroup perspective.
de Santis J, de Sousa G, Queiroz R, Candido M, Almeida F, de Rezende C
Hum Cell. 2025; 38(2):55.
PMID: 39960575
DOI: 10.1007/s13577-025-01181-3.
Comprehensive analysis reveals the tumor suppressor role of macrophage signature gene FCER1G in hepatocellular carcinoma.
Kong D, Zhang Y, Jiang L, Long N, Wang C, Qiu M
Sci Rep. 2025; 15(1):3995.
PMID: 39893200
PMC: 11787346.
DOI: 10.1038/s41598-025-88071-8.
The Single-Cell Landscape of Peripheral and Tumor-infiltrating Immune Cells in HPV- HNSCC.
Galvani R, Rojas A, Matuck B, Rupp B, Kumar N, Huynh K
bioRxiv. 2025; .
PMID: 39868329
PMC: 11760799.
DOI: 10.1101/2025.01.14.632928.
Arginine metabolism in myeloid cells in health and disease.
Karadima E, Chavakis T, Alexaki V
Semin Immunopathol. 2025; 47(1):11.
PMID: 39863828
PMC: 11762783.
DOI: 10.1007/s00281-025-01038-9.
Macrophage Infiltration and ITGB2 Expression in ESCC: A Novel Correlation.
Huang T, Wei L, Zhou H, Liu J
Cancer Med. 2025; 14(2):e70604.
PMID: 39825491
PMC: 11742006.
DOI: 10.1002/cam4.70604.
Bisphosphonate-mineralized nano-IFNγ suppresses residual tumor growth caused by incomplete radiofrequency ablation through metabolically remodeling tumor-associated macrophages.
Yan Z, Wang B, Shen Y, Ren J, Chen M, Jiang Y
Theranostics. 2025; 15(3):1057-1076.
PMID: 39776793
PMC: 11700868.
DOI: 10.7150/thno.100998.
Targeting immune checkpoints on myeloid cells: current status and future directions.
Ma C, Li Y, Li M, Lv C, Tian Y
Cancer Immunol Immunother. 2025; 74(2):40.
PMID: 39751898
PMC: 11699031.
DOI: 10.1007/s00262-024-03856-6.
Development of anti-cancer drugs for tumor-associated macrophages: a comprehensive review and mechanistic insights.
Bai B, Xie S, Wang Y, Wu F, Chen Y, Bian J
Front Mol Biosci. 2024; 11:1463061.
PMID: 39717759
PMC: 11663717.
DOI: 10.3389/fmolb.2024.1463061.
Napabucasin-loaded PLGA nanoparticles trigger anti-HCC immune responses by metabolic reprogramming of tumor-associated macrophages.
Song Z, Chen H, Wang X, Zhang Z, Li H, Zhao H
J Transl Med. 2024; 22(1):1125.
PMID: 39707412
PMC: 11662498.
DOI: 10.1186/s12967-024-05917-x.
Disrupting Notch signaling related HES1 in myeloid cells reinvigorates antitumor T cell responses.
Kim M, Kang H, Baek J, Cho M, Chung E, Kim S
Exp Hematol Oncol. 2024; 13(1):122.
PMID: 39702544
PMC: 11660887.
DOI: 10.1186/s40164-024-00588-2.
Adipocyte-derived CXCL10 in obesity promotes the migration and invasion of ovarian cancer cells.
Wang Z, Ou Q, Liu Y, Liu Y, Zhu Q, Feng J
J Ovarian Res. 2024; 17(1):245.
PMID: 39702497
PMC: 11656578.
DOI: 10.1186/s13048-024-01568-0.